Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Homologous Recombination Deficiency: Concepts, Definitions, and Assays.
Oncologist. 2022 Mar 11;27(3):167-174. doi: 10.1093/oncolo/oyab053.
Oncologist. 2022.
PMID: 35274707
Free PMC article.
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Vega DM, Nishimura KK, Zariffa N, Thompson JC, Hoering A, Cilento V, Rosenthal A, Anagnostou V, Baden J, Beaver JA, Chaudhuri AA, Chudova D, Fine AD, Fiore J, Hodge R, Hodgson D, Hunkapiller N, Klass DM, Kobie J, Peña C, Pennello G, Peterman N, Philip R, Quinn KJ, Raben D, Rosner GL, Sausen M, Tezcan A, Xia Q, Yi J, Young AG, Stewart MD, Carpenter EL, Aggarwal C, Allen J.
Vega DM, et al.
JCO Precis Oncol. 2022 Aug;6:e2100372. doi: 10.1200/PO.21.00372.
JCO Precis Oncol. 2022.
PMID: 35952319
Free PMC article.
Item in Clipboard
Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making.
LeBlanc TW, Russell NH, Hernandez-Aldama L, Panter C, Bell TJ, Welch V, Vega DM, O'Hara L, Stein J, Barclay M, Peloquin F, Brown A, Healy J, Morgan L, Gater A, Hohman R, Amer K, Maze D, Walter RB.
LeBlanc TW, et al. Among authors: vega dm.
Oncol Ther. 2022 Dec;10(2):421-440. doi: 10.1007/s40487-022-00200-9. Epub 2022 Jun 13.
Oncol Ther. 2022.
PMID: 35695986
Free PMC article.
Item in Clipboard
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Prior Therapies Work Group.
Osarogiagbon RU, Vega DM, Fashoyin-Aje L, Wedam S, Ison G, Atienza S, De Porre P, Biswas T, Holloway JN, Hong DS, Wempe MM, Schilsky RL, Kim ES, Wade JL 3rd.
Osarogiagbon RU, et al. Among authors: vega dm.
Clin Cancer Res. 2021 May 1;27(9):2408-2415. doi: 10.1158/1078-0432.CCR-20-3854. Epub 2021 Feb 9.
Clin Cancer Res. 2021.
PMID: 33563637
Free PMC article.
Item in Clipboard
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement.
Kim ES, Uldrick TS, Schenkel C, Bruinooge SS, Harvey RD, Magnuson A, Spira A, Wade JL, Stewart MD, Vega DM, Beaver JA, Denicoff AM, Ison G, Ivy SP, George S, Perez RP, Spears PA, Tap WD, Schilsky RL.
Kim ES, et al. Among authors: vega dm.
Clin Cancer Res. 2021 May 1;27(9):2394-2399. doi: 10.1158/1078-0432.CCR-20-3852. Epub 2021 Feb 9.
Clin Cancer Res. 2021.
PMID: 33563632
Item in Clipboard
A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-Making.
Wempe MM, Stewart MD, Glass D, Lasiter L, Vega DM, Ramamurthy N, Allen J, Sigal EV.
Wempe MM, et al. Among authors: vega dm.
Am Health Drug Benefits. 2020 Jun;13(3):110-119.
Am Health Drug Benefits. 2020.
PMID: 32699571
Free PMC article.
Item in Clipboard
Cite
Cite